Register for PCMG!
The Primary Care Metabolic Group (PCMG) is a national educational initiative providing comprehensive metabolic disease education. PCMG’s mission is to provide a representative forum for primary care clinicians involved in metabolic disease management and raise standards of patient care through the dissemination of best practices, education programs, and communication among members.
Therapeutic areas covered by PCMG include:
- Diabetes
- Thyroid Disease
- Metabolic Syndrome
- Obesity
- Osteoporosis
- Co-morbidities of metabolic disease including cardiovascular disease
Benefits of membership include:
- Access to the PCMG website that includes up-to-date information on diabetes management including organizational activities, medical developments, relevant article highlights and commentaries, case studies and meeting information;
- A forum where Primary Care colleagues can discuss medical issues specifically related to metabolic diseases;
- Opportunities for FREE CME;
- Possible research opportunities and
- Other activities based upon suggestions of the PCMG steering committee.
NEW Commentary: Depression and Diabetes: An Update from the 69th Annual ADA Scientific Sessions
7/2/2009: Presentations at the recent ADA meetings in New Orleans contribute to our understanding of the association between depression and bad diabetes outcomes. We learned that people who have diabetes are 1.5 to 2 times more likely to be depressed than people in the general population, and that depression in people with diabetes is associated with higher blood glucose levels, higher complication and mortality rates, and higher health care costs. Read More
NEW Commentary: Evaluation and Management of Patients with Low HDL Cholesterol
6/9/2009: Low levels of high-density lipoprotein cholesterol (HDL-C) can significantly increase one’s cardiovascular risk and be challenging to treat. Coronary artery disease risk remains elevated in patients with low HDL-C even after metabolic improvement for obesity, blood pressure, total cholesterol and LDL-C. The term “isolated low HDL cholesterol” refers to the situation in which total cholesterol or LDL-C are in the “ideal range” but the HDL-C is low. Read More
NEW Commentary: Issues of Adherence: Getting Patients With Metabolic Syndrome to Goal
5/21/2009: Cardiovascular disease (CVD) is the leading cause of death worldwide in adult men and women and is responsible for as many as 17 million deaths annually in the U.S. The metabolic syndrome is a disorder comprised of major risk factors that can increase a patient’s risk for CVD. National guidelines recommend we treat patients who meet the criteria for metabolic syndrome as a potential secondary target of therapy. Read More
FREE CME!
Check out PCMG's new CME activity "Article Insights Volume 6: Managing the Patient with Type 2 Diabetes When Lifestyle Intervention and Metformin Don’t Achieve the Target Glycemic Goal." The activity is worth 2.0 AAFP Prescribed credits with EB CME designation and 1.0 AMA PRA Category 1 credit. Click here to read the activity!
NEW Commentary: New Diabetes Drug, Saxagliptin, on the Horizon Following Added Safety Review
4/21/09: Saxagliptin, a new oral antihyperglycemic drug being developed by Bristol-Myers Squibb Co. is the first drug to pass the hurdle of added scrutiny under FDA’s new safety guidelines for diabetes treatments entering the market. On April 1, the FDA Endocrinologic and Metabolic Drugs Advisory Committee voted 10 – 2 that there is adequate evidence to demonstrate that saxagliptin is not associated with excess cardiovascular risk. Read More
NEW Patient Education Resources! (Courtesty of Richard R. Rubin, PhD, CDE)
FREE CME!
Check out PCMG's new CME activity "Article Insights Volume 5: Applying the 2008 ADA/EASD Treatment Algorithm to Primary Care." The activity is worth 2.0 AAFP Prescribed credits with EB CME designation and 1.0 AMA PRA Category 1 credit. Click here to read the activity!
New Resources from The Endocrine Society and The Hormone Foundation:
To check out The Endocrine Society’s Current Practice Guidelines click here.
To check out The Endocrine Society’s FREE CME click here.
To check out The Hormone Foundation’s patient education resources click here.
Education and Compliance Tips for Patients with Diabetes
In July 2008, PCMG conducted a contest among PCMG members on education and compliance tips for patients with diabetes. We asked you to share some of your more innovative approaches to helping your patients comply with their treatment and lifestyle modifications as well as educating your patients on the progressive nature of diabetes. We received lots of wonderful tips and suggestions and wanted to share them! We hope you find these tips useful and practical to your everyday primary care practice. Read More
